This announcement just proves the superiority of design and tissue, other companies had to do animal trials for 2 years+ on pigs, sheep and cows before proceeding ahead with human trials.
For Admedus, to have a leading specialist recommend human trials after only having the SAVR implanted in sheep shows beyond doubt that the company has come up with a great revolutionary product that will benefit many heart patients and grow the company.
- Forums
- ASX - By Stock
- Ann: SAVR Clinical Trial
This announcement just proves the superiority of design and...
-
-
- There are more pages in this discussion • 64 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$9.86 |
Change
-1.040(9.54%) |
Mkt cap ! $203.1M |
Open | High | Low | Value | Volume |
$10.50 | $10.79 | $9.30 | $1.056M | 106.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 78 | $9.86 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$10.00 | 500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 608 | 9.850 |
1 | 65 | 9.840 |
1 | 500 | 9.830 |
1 | 958 | 9.800 |
3 | 3630 | 9.700 |
Price($) | Vol. | No. |
---|---|---|
10.000 | 500 | 1 |
10.160 | 59 | 1 |
10.170 | 132 | 3 |
10.180 | 130 | 1 |
10.200 | 1039 | 3 |
Last trade - 13.16pm 06/09/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |